Summary:
In a 36-year-old male with ileocolic Crohn's disease (CD) no long-lasting remission was obtained by treatment with corticosteroids, mesalazine, azathioprine and antibiotics. Surgical interventions due to relapsing fistulae and abscesses resulted in the removal of >1.5 m of small bowel and left only 40 cm of large bowel. In July 2000, a new fistula and abscess developed. The combination of corticosteroids, mesalazine, ciprofloxacin, metronidazol, azathioprine, formula diet and anti-TNF-α antibody largely reduced clinical activity, and resection of fistula and abscess were successful. Despite clinical remission, histology showed activity in the small bowel and the colon. In March 2001, stem cell mobilization chemotherapy with cyclophosphamide was performed. It induced an endoscopic remission for 9 months, which was maintained on azathioprine and corticosteroids. After relapse, in March 2002, high-dose chemotherapy with cyclophosphamide and reinfusion of T-cell-depleted autologous peripheral CD34+ blood stem cells were performed. This led to a complete clinical, endoscopical and histological remission for 9 months without any treatment. Thereafter, endoscopy showed initial aphthous lesions with minimal histological signs of inflammation. The patient is asymptomatic, but low-dose prednisolone and methotrexate are prophylactically given. Immunoablative chemotherapy followed by autologous peripheral blood stem cell transplantation may be a beneficial therapeutic option in complicated refractory CD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Podolsky DK . Inflammatory bowel disease. N Engl J Med 2002; 347: 417–429.
Shanahan F . Crohn's disease. Lancet 2002; 359:62–69.
Sandborn WJ, Targan SR . Biological therapy of inflammatory bowel disease. Gastroenterology 2002; 122: 1592–1608.
Yin JA, Jowitt SN . Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992; 9: 31–33.
Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643–645.
Tyndall A, Black C, Finke J et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997; 349: 254.
Burt KR, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–784.
Hawkey CJ, Snowden JA, Lobo A et al. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues. Gut 2000; 46: 869–872.
Lopez-Cubero SO, Sullivan KM, McDonald GB . Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998; 114: 433–440.
Kashyap A, Forman SJ . Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998; 103: 651–652.
Musso M, Porretto F, Crescimanno A et al. Crohn's disease complicated by relapsed extranodal Hodgkin's lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplant 2000; 26: 921–923.
Soderholm JD, Malm C, Juliusson G, Sjodahl R . Long-term endoscopic remission of Crohn's disease after autologous stem cell transplantation for acute myeloid leukaemia. Scand J Gastroenterol 2002; 37: 613–616.
Burt RK, Traynor A, Oyama Y, Craig R . High dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease. Blood 2003; 101: 2064–2066.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kreisel, W., Potthoff, K., Bertz, H. et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 32, 337–340 (2003). https://doi.org/10.1038/sj.bmt.1704134
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704134
Keywords
This article is cited by
-
Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis
Systematic Reviews (2022)
-
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Clinical Rheumatology (2019)
-
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
Stem Cell Research & Therapy (2017)
-
Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide
Bone Marrow Transplantation (2017)
-
Stem cell autograft and allograft in autoimmune diseases
Clinical and Experimental Medicine (2016)